US2022233621A1PendingUtilityA1

Pharmaceutical compositions containing cannabis, uses thereof and methods for improving energy levels and/or alleviating fatigue

Assignee: EXZELL PHARMA INCPriority: Apr 6, 2018Filed: Apr 11, 2022Published: Jul 28, 2022
Est. expiryApr 6, 2038(~11.7 yrs left)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658A61K 31/714A61K 31/7004A61K 36/77A61K 36/82A61K 31/519A61P 25/00A61K 31/404A61K 31/05A61K 36/185A61K 31/352
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition containing Cannabis for increasing energy levels and/or alleviating fatigue in a patient. Also provided are a use of the pharmaceutical composition for increasing energy levels and/or alleviating fatigue in a patient, and methods for increasing energy levels and/or alleviating fatigue. The pharmaceutical composition preferably includes a combination of therapeutically effective amounts of one or more of the following medicinal ingredients: Cannabis, an herb, vitamins, and/or fructose.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A tablet, caplet, capsule or dermal patch consisting of a  Cannabis  extract, a  Paullinia cupana  extract: Vitamin B9, Vitamin B 12 and fructose. 
     
     
         2 . The tablet, caplet, capsule or dermal patch of  claim 1  wherein the tablet, caplet, capsule or dermal patch consists of from about 25 mg to about 1000 mg of the  Paullinia cupana  extract per dose. 
     
     
         3 . The tablet, caplet, capsule or dermal patch of  claim 2  wherein the tablet, caplet, capsule or dermal patch consists of from about 100 mg to about 200 mg of the  Paullinia cupana  extract per dose. 
     
     
         4 . The tablet, caplet, capsule or dermal patch of  claim 1  wherein the tablet, caplet, capsule or dermal patch consists of from about 1 mg to about 30 mg of the  Cannabis  extract per dose. 
     
     
         5 . The tablet, caplet, capsule or dermal patch of  claim 4  wherein the tablet, caplet, capsule or dermal patch consists of from about 2.5 mg to about 10 mg of the  Cannabis  extract per dose. 
     
     
         6 . The tablet, caplet, capsule or dermal patch of  claim 1  wherein the tablet, caplet, capsule or dermal patch consists of from about 25 mcg to about 2000 mcg of Vitamin B9 per dose. 
     
     
         7 . The tablet, caplet, capsule or dermal patch of  claim 6  wherein the tablet, caplet, capsule or dermal patch consists of from about 250 mcg to about 400 mcg of Vitamin B9 per dose. 
     
     
         8 . The tablet, caplet, capsule or dermal patch of  claim 1  wherein the tablet, caplet, capsule or dermal patch consists of from about 250 mcg to about 2000 mcg of Vitamin B 12 per dose. 
     
     
         9 . The tablet, caplet, capsule or dermal patch of  claim 8  wherein the tablet, caplet, capsule or dermal patch consists of from about 450 mcg to about 550 mcg of Vitamin B 12 per dose. 
     
     
         10 . The tablet, caplet, capsule or dermal patch of  claim 9  wherein the tablet, caplet, capsule or dermal patch consists of from about 25 mg to about 100 mg of the fructose per dose. 
     
     
         11 . The tablet, caplet, capsule or dermal patch of  claim 10  wherein the tablet, caplet, capsule or dermal patch consists of from about 30 mg to about 70 mg of the fructose per dose.

Join the waitlist — get patent alerts

Track US2022233621A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.